LPL Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6M Buy
95,466
+13,746
+17% +$2.63M ﹤0.01% 1548
2026
Q1
$15M Sell
81,720
-7,817
-9% -$1.44M ﹤0.01% 1684
2025
Q4
$15.8M Buy
89,537
+19,373
+28% +$3.17M ﹤0.01% 1569
2025
Q3
$9.83M Sell
70,164
-30
-0% -$4.05K ﹤0.01% 1876
2025
Q2
$8.82M Buy
70,194
+25,873
+58% +$3.22M ﹤0.01% 1840
2025
Q1
$6.06M Buy
44,321
+18,183
+70% +$2.6M ﹤0.01% 1996
2024
Q4
$4M Sell
26,138
-18,253
-41% -$3.08M ﹤0.01% 2254
2024
Q3
$8.6M Sell
44,391
-7,107
-14% -$1.49M ﹤0.01% 1581
2024
Q2
$11.9M Buy
51,498
+3,333
+7% +$724K 0.01% 1259
2024
Q1
$10.4M Buy
48,165
+3,095
+7% +$725K 0.01% 1302
2023
Q4
$11.7M Sell
45,070
-5,740
-11% -$1.41M 0.01% 1157
2023
Q3
$13.1M Buy
50,810
+8,781
+21% +$2.35M 0.01% 1011
2023
Q2
$12M Sell
42,029
-500
-1% -$149K 0.01% 1043
2023
Q1
$11.8M Sell
42,529
-22
-0.1% -$6.09K 0.01% 1006
2022
Q4
$11.8M Buy
42,551
+1,526
+4% +$431K 0.01% 941
2022
Q3
$11M Sell
41,025
-4,788
-10% -$1.02M 0.01% 909
2022
Q2
$9.34M Sell
45,813
-283
-0.6% -$57.9K 0.01% 1001
2022
Q1
$9.71M Buy
46,096
+112
+0.2% +$24.4K 0.01% 1019
2021
Q4
$11M Sell
45,984
-3,273
-7% -$842K 0.01% 964
2021
Q3
$13.9M Buy
49,257
+11,320
+30% +$3.71M 0.01% 778
2021
Q2
$13.1M Sell
37,937
-3,433
-8% -$1.04M 0.01% 772
2021
Q1
$11.6M Buy
41,370
+1,545
+4% +$417K 0.01% 758
2020
Q4
$9.75M Buy
39,825
+2,739
+7% +$707K 0.01% 758
2020
Q3
$10.5M Buy
37,086
+4,110
+12% +$1.15M 0.02% 620
2020
Q2
$8.82M Buy
32,976
+1,768
+6% +$531K 0.02% 636
2020
Q1
$9.87M Sell
31,208
-2,342
-7% -$711K 0.02% 501
2019
Q4
$9.96M Sell
33,550
-383
-1% -$106K 0.02% 577
2019
Q3
$7.9M Sell
33,933
-24
-0.1% -$5.59K 0.02% 616
2019
Q2
$7.94M Sell
33,957
-11,202
-25% -$2.59M 0.02% 599
2019
Q1
$10.7M Sell
45,159
-25
-0.1% -$7.87K 0.02% 471
2018
Q4
$13.6M Buy
45,184
+2,518
+6% +$804K 0.04% 365
2018
Q3
$15.1M Sell
42,666
-272
-0.6% -$93.7K 0.04% 364
2018
Q2
$12.5M Sell
42,938
-5,013
-10% -$1.41M 0.03% 401
2018
Q1
$13.1M Sell
47,951
-2,931
-6% -$910K 0.04% 373
2017
Q4
$16.2M Buy
50,882
+5,501
+12% +$1.76M 0.05% 302
2017
Q3
$14.2M Buy
45,381
+21,847
+93% +$6.47M 0.05% 294
2017
Q2
$6.39M Buy
23,534
+11,126
+90% +$2.94M 0.02% 480
2017
Q1
$3.38M Buy
12,408
+2,075
+20% +$587K 0.02% 574
2016
Q4
$3.01M Sell
10,333
-63
-0.6% -$18.7K 0.02% 600
2016
Q3
$3.24M Buy
10,396
+2,034
+24% +$602K 0.03% 539
2016
Q2
$2.07M Sell
8,362
-32,526
-80% -$8.57M 0.02% 752
2016
Q1
$10.9M Sell
40,888
-5,476
-12% -$1.45M 0.03% 415
2015
Q4
$13.8M Buy
46,364
+29,143
+169% +$8.37M 0.04% 357
2015
Q3
$4.93M Buy
17,221
+773
+5% +$255K 0.03% 466
2015
Q2
$6.66M Sell
16,448
-8,566
-34% -$3.44M 0.03% 414
2015
Q1
$10.4M Buy
25,014
+3,606
+17% +$1.42M 0.05% 298
2014
Q4
$7.27M Sell
21,408
-1,588
-7% -$514K 0.04% 359
2014
Q3
$7.44M Buy
22,996
+4,143
+22% +$1.37M 0.04% 337
2014
Q2
$5.95M Buy
18,853
+1,635
+9% +$492K 0.03% 410
2014
Q1
$5.27M Sell
17,218
-3,327
-16% -$1.06M 0.03% 423
2013
Q4
$5.74M Sell
20,545
-899
-4% -$233K 0.04% 402
2013
Q3
$5.12M Buy
21,444
+4,024
+23% +$901K 0.03% 408
2013
Q2
$3.75M Buy
+17,420
New +$3.72M 0.03% 473

Other funds holding BIIB

LPL Financial's BIIB Position: Q2 2026 in Review

LPL Financial increased its Biogen (BIIB) stake by 17% in Q2 2026, buying an estimated $2.63M and bringing the position to 95,466 shares worth $20.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

LPL Financial first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. 577 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • LPL Financial held 95,466 shares of Biogen worth $20.6M as of Q2 2026.
  • LPL Financial bought 13,746 Biogen shares in Q2 2026, an estimated $2.63M.
  • Biogen made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #1548 holding.
  • LPL Financial first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • 577 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.